Insider activities archive   |   Recent insider buys   |   Top 10 insider buys   |   Search Insiders!



Insider Trading: SEATTLE GENETICS INC /WA

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of SEATTLE GENETICS INC /WA in the last 24 months are illustrated in figures 1 and 2. Table 1 shows the monthly insider trading data of SEATTLE GENETICS INC /WA since year 2005. Table 2 shows the detailed insider transactions of SEATTLE GENETICS INC /WA since 2005. The reporting company's ticker symbol is SGEN. The reporting company's CIK number is 1060736.

The total value of stock buying since 2005 is $103,287,975. The total value of stock sales is $92,438,975. The total value of stock exercises is $2,783,963.


1 year stock price chart,   1 day stock price chart
opopp
opopopop

Figure 1. Monthly insider transaction values at SEATTLE GENETICS INC /WA (SGEN) in the past 24 months. The trade values of insider stock buys, sales, and option exercises are in logarithmic scale as shown on the right axis labels. The detailed monthly and daily insider transactions are listed in the 2 tables below.

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2007

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2008

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • $72,743k

    $7,274k

    $727k

    $72k

  • Buy
  • Sale
  • Option Exercise

Figure 2. Average prices of insider buys, sales, and option exercises at SEATTLE GENETICS INC /WA (SGEN) in the past 24 months. See table 2 for insider transaction details.

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2007

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • 08

  • 09

  • 10

  • 11

  • 12

  • 01 2008

  • 02

  • 03

  • 04

  • 05

  • 06

  • 07

  • $12.63

    $9.47

    $6.32

    $3.16



Table 1. Monthly summaries of insider stock purchases, sales, and option exercises for SEATTLE GENETICS INC /WA (SGEN).
Trading Period
year-month  
Insider Buying     
Shares               Value ($)
Insider Sales     
Shares               Value ($)
Option Exercises     
Shares               Value ($)
2008-05 0 0 761,936 7,709,540 0 0
2008-03 701,140 5,601,920 0 0 0 0
2008-02 388,136 3,491,945 0 0 0 0
2008-01 5,510,589 49,562,366 0 0 6,000 25,080
2007-12 0 0 42,184 532,783 25,000 28,250
2007-09 2,000 21,240 234,350 2,739,782 254,979 1,309,191
2007-08 0 0 257,332 2,853,100 216,668 650,004
2007-05 0 0 84,891 872,132 84,891 418,344
2007-04 0 0 25,000 238,499 25,000 168,000
2007-02 0 0 8,398,938 72,743,148 43,472 185,094
2007-01 0 0 25,000 130,487 0 0
2006-12 0 0 300,000 1,711,185 0 0
2006-11 0 0 150,000 828,695 0 0
2006-10 0 0 100,000 495,457 0 0
2006-08 1,058,406 4,259,072 0 0 0 0
2006-06 5,533,082 22,382,749 0 0 0 0
2006-05 1,979,380 10,391,742 0 0 0 0
2005-09 0 0 97,000 578,922 0 0
2005-08 0 0 103,000 612,953 0 0
2005-05 49,052 234,950 76,500 392,292 0 0
2005-04 607,103 2,425,976 0 0 0 0
2005-03 989,701 4,916,015 0 0 0 0

Table 2. Detailed insider stock purchases, sales, and option exercises for SEATTLE GENETICS INC /WA (SGEN)
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2008-05-16 Akkaraju Srinivas (Director) Sale 42,059 10.39 436,993
2008-05-15 Akkaraju Srinivas (Director) Sale 98,758 10.14 1,001,406
2008-05-15 Jp Morgan Partners Bhca Lp (10% Owner) Sale 100,000 10.14 1,014,000
2008-05-14 H&q Employee Venture Fund 2000, L.p. (10% Owner) Sale 122,893 10.10 1,241,219
2008-05-14 Jpmp Global Investors L P (10% Owner) Sale 122,893 10.10 1,241,219
2008-05-14 Akkaraju Srinivas (Director) Sale 121,365 10.10 1,225,786
2008-05-13 H&q Employee Venture Fund 2000, L.p. (10% Owner) Sale 51,536 10.06 518,452
2008-05-13 Jpmp Global Investors L P (10% Owner) Sale 51,536 10.06 518,452
2008-05-13 Akkaraju Srinivas (Director) Sale 50,896 10.06 512,013
2008-03-18 Baker Felix (Director) Purchase 72,343 8.02 580,319
2008-03-17 Baker Felix (Director) Purchase 97,064 7.80 757,185
2008-03-14 Baker Felix (Director) Purchase 174,999 8.07 1,412,142
2008-03-13 Baker Felix (Director) Purchase 54,406 7.93 431,170
2008-03-12 Baker Felix (Director) Purchase 16,256 7.98 129,745
2008-02-11 Baker Felix (Director) Purchase 48,751 9.06 441,458
2008-02-08 Baker Felix (Director) Purchase 113,356 8.97 1,016,903
2008-02-07 Baker Felix (Director) Purchase 32,540 9.00 292,837
2008-01-23 Baker Felix (Director) Purchase 100,935 9.03 911,219
2008-01-22 Berger Franklin M (Director) Purchase 528 9.12 4,815
2008-01-22 Baker Felix (Director) Purchase 87,596 8.78 768,871
2008-01-18 Baker Felix (Director) Purchase 2,600,000 9.00 23,400,000
2008-01-17 Gryska David W (Director) Option Exercise 6,000 4.18 25,080
2007-12-20 Dobmeier Eric (Chief Business Officer) Option Exercise 5,000 5.25 26,250
2007-12-14 Lippman Marc E (Director) Option Exercise 20,000 .10 2,000
2007-12-10 Akkaraju Srinivas (Director) Sale 20,960 12.63 264,724
2007-12-10 Jp Morgan Partners Bhca Lp (10% Owner) Sale 21,224 12.63 268,059
2007-09-26 Simpson Todd E (Chief Financial Officer) Sale 32,250 11.93 384,688
2007-09-26 Simpson Todd E (Chief Financial Officer) Option Exercise 32,250 5.08 163,668
2007-09-26 Rosenberg Morris (Sr. VP, Development) Sale 15,000 11.94 179,025
2007-09-26 Rosenberg Morris (Sr. VP, Development) Option Exercise 15,000 6.72 100,800
2007-09-25 Dobmeier Eric (Chief Business Officer) Option Exercise 20,629 3.77 77,840
2007-09-20 Dobmeier Eric (Chief Business Officer) Sale 44,600 11.63 521,690
2007-09-20 Dobmeier Eric (Chief Business Officer) Option Exercise 44,600 5.25 234,150
2007-09-19 Dobmeier Eric (Chief Business Officer) Sale 55,400 11.62 641,910
2007-09-19 Dobmeier Eric (Chief Business Officer) Option Exercise 55,400 5.16 283,154
2007-09-17 Lippman Marc E (Director) Purchase 2,000 10.62 21,240
2007-08-22 Siegall Clay B (President and CEO) Sale 74,000 11.07 819,141
2007-08-21 Siegall Clay B (President and CEO) Sale 73,032 11.00 804,247
2007-08-21 Siegall Clay B (President and CEO) Option Exercise 113,700 3.00 341,100
2007-08-20 Siegall Clay B (President and CEO) Sale 71,300 11.16 795,513
2007-08-20 Siegall Clay B (President and CEO) Option Exercise 71,300 3.00 213,900
2007-08-17 Siegall Clay B (President and CEO) Sale 31,668 11.17 353,731
2007-08-17 Siegall Clay B (President and CEO) Option Exercise 31,668 3.00 95,004
2007-05-17 Trailsmith Pamela A (Chief Scientific Officer) Sale 59,891 10.25 613,882
2007-05-17 Trailsmith Pamela A (Chief Scientific Officer) Option Exercise 59,891 4.18 250,344
2007-05-17 Rosenberg Morris (Sr. VP, Development) Sale 25,000 10.33 258,250
2007-05-17 Rosenberg Morris (Sr. VP, Development) Option Exercise 25,000 6.72 168,000
2007-04-27 Rosenberg Morris (Sr. VP, Development) Sale 25,000 9.54 238,499
2007-04-27 Rosenberg Morris (Sr. VP, Development) Option Exercise 25,000 6.72 168,000
2007-02-14 Baker Felix (Director) Sale 2,872,000 8.74 25,047,955
2007-02-09 Jpmp Global Investors L P (10% Owner) Sale 2,014,730 8.57 17,266,236
2007-02-09 Akkaraju Srinivas (Director) Sale 2,015,000 8.57 17,268,550
2007-02-09 Dobmeier Eric (Sr. VP, Corporate Development) Sale 50,000 8.95 447,318
2007-02-09 Dobmeier Eric (Sr. VP, Corporate Development) Option Exercise 43,472 4.26 185,094
2007-02-06 Gallen Jonathan (10% Owner) Sale 175,000 9.23 1,615,320
2007-01-03 Gallen Jonathan (10% Owner) Sale 25,000 5.22 130,487
2006-12-15 Gallen Jonathan (10% Owner) Sale 250,000 5.70 1,425,000
2006-12-14 Gallen Jonathan (10% Owner) Sale 50,000 5.72 286,185
2006-11-10 Gallen Jonathan (10% Owner) Sale 50,000 5.45 272,615
2006-11-09 Gallen Jonathan (10% Owner) Sale 100,000 5.56 556,080
2006-10-12 Gallen Jonathan (10% Owner) Sale 71,156 4.95 352,414
2006-10-11 Gallen Jonathan (10% Owner) Sale 17,644 4.95 87,263
2006-10-10 Gallen Jonathan (10% Owner) Sale 11,200 4.98 55,780
2006-08-14 Baker Felix (Director) Purchase 50,000 4.05 202,499
2006-08-11 Baker Felix (Director) Purchase 143,813 4.03 579,436
2006-08-10 Baker Felix (Director) Purchase 4,852 4.03 19,569
2006-08-09 Baker Felix (Director) Purchase 263,486 4.05 1,067,103
2006-08-08 Baker Felix (Director) Purchase 10,000 4.05 40,477
2006-08-07 Baker Felix (Director) Purchase 38,700 4.03 156,118
2006-08-04 Baker Felix (Director) Purchase 24,000 4.05 97,194
2006-08-03 Baker Felix (Director) Purchase 25,000 4.00 99,916
2006-08-02 Baker Felix (Director) Purchase 31,800 3.70 117,627
2006-06-29 Baker Felix (Director) Purchase 83,100 4.08 338,781
2006-06-28 Baker Felix (Director) Purchase 316,000 4.02 1,269,497
2006-06-27 Baker Felix (Director) Purchase 132,150 4.03 533,006
2006-06-26 Baker Felix (Director) Purchase 140,000 4.00 560,222
2006-06-23 Baker Felix (Director) Purchase 35,347 4.07 143,769
2006-06-22 Baker Felix (Director) Purchase 31,426 4.06 127,475
2006-06-13 Baker Felix (Director) Purchase 117,942 3.99 470,218
2006-06-09 Baker Felix (Director) Purchase 1,956,600 4.06 7,934,011
2006-05-24 Baker Felix (Director) Purchase 1,129,015 5.25 5,927,327
2005-09-13 Siegall Clay B (President and CEO) Sale 73,000 5.97 435,810
2005-09-09 Siegall Clay B (President and CEO) Sale 24,000 5.96 143,112
2005-08-02 Siegall Clay B (President and CEO) Sale 103,000 5.95 612,953
2005-05-05 Carroll Tim (CFO) Sale 76,500 5.13 392,292
2005-05-04 Baker Felix (Director) Purchase 25,000 4.79 119,745
2005-04-29 Baker Felix (Director) Purchase 306,748 4.00 1,225,761
2005-03-30 Baker Felix (Director) Purchase 40,100 4.96 198,970
2005-03-23 Baker Felix (Director) Purchase 468,642 4.97 2,327,998

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of SEATTLE GENETICS INC /WA (symbol SGEN, CIK number 1060736) see the Securities and Exchange Commission (SEC) website.

© 2005-2008, insider-monitor.com. All rights reserved.